Essais liés2clinical trials
VillePraguelocalisation
PaysCzechialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03232073

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Nipocalimab Myasthénie Phase 3 NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis RECRUITING
Ponesimod SEP Phase 3 NCT03232073 Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis COMPLETED